콜레라 백신 시장 규모, 점유율, 성장 분석 : 제품 유형별, 투여 경로별, 최종사용자별, 연령층별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)

Global Cholera Vaccines Market size was valued at USD 80.2 million in 2023 and is poised to grow from USD 86.7 million in 2024 to USD 161.66 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Cholera, a serious bacterial infection transmitted through contaminated food and water, poses a significant global health threat marked by severe diarrhea, dehydration, and other debilitating symptoms. The Vibrio cholera bacterium causes this illness, which can manifest within hours to days, and can be fatal if not treated promptly. Key contributors to cholera outbreaks include poor hygiene, inadequate sanitation, and lack of access to clean drinking water. Fortunately, vaccination offers a vital solution, promoting immunity by exposing individuals to a small number of live cholera bacteria. Administered through various methods including intravenous, intramuscular, or oral routes, cholera vaccines are instrumental in combating this infectious disease, playing a crucial role in public health strategies endorsed by organizations like the World Health Organization.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segments Analysis

Global Cholera Vaccines Market is segmented by Type, Product, Route of Administration, End User, Age Group, Distribution Channel and region. Based on Type, the market is segmented into Whole Cell V. Cholerae O1 with Recombinant B- subunit and Killed Oral O1 and O139. Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol and Other Products. Based on Route of Administration, the market is segmented into Injectables Vaccines and Oral Vaccines. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on Age Group, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholera Vaccines Market

The growth of the global cholera vaccines market is primarily driven by innovative approaches in developing new vaccines, heightened awareness surrounding cholera prevention, and the prevalence of unhealthy lifestyle choices, such as inadequate sanitation and consumption of contaminated food. Furthermore, intensified government initiatives and vaccination campaigns have bolstered market expansion. However, the market may face challenges due to stringent FDA regulations and an extended approval timeline for new pharmaceutical products, which can impede the introduction of potentially effective cholera vaccines. Overall, the interplay of these factors shapes the dynamic landscape of the cholera vaccines market on a global scale.

Restraints in the Global Cholera Vaccines Market

One of the major factors hindering the growth of the global cholera vaccines market is the prolonged time required for vaccine development, coupled with the stringent regulatory approval processes in place. These challenges can create delays in bringing new vaccines to market, which may ultimately impact the availability of effective cholera prevention methods. As a result, these factors can constrain the overall expansion and accessibility of cholera vaccines, especially in regions where the disease is prevalent. Consequently, addressing these hurdles is crucial for enhancing the market's growth trajectory and improving public health outcomes related to cholera.

Market Trends of the Global Cholera Vaccines Market

The global cholera vaccines market is experiencing a significant upward trend, propelled by the alarming rise in cholera cases linked to inadequate sanitation and hygiene, particularly in rural and remote regions. As cholera outbreaks become more prevalent, public health initiatives and governmental support are heightening awareness about the critical role of vaccination in combatting this preventable disease. The increasing focus on disease prevention, coupled with advancements in vaccine technology and distribution strategies, is further driving demand. Moreover, collaborative efforts between organizations and health authorities to enhance accessibility underpin a promising growth trajectory for the cholera vaccines market in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cholera Vaccines Market Size by Type & CAGR (2025-2032)

• Market Overview
• Whole Cell V. Cholerae O1 with Recombinant B- subunit
• Killed Oral O1 and O139

Global Cholera Vaccines Market Size by Product & CAGR (2025-2032)

• Market Overview
• Vaxchora
• Dukoral
• Shanchol
• Other Products

Global Cholera Vaccines Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Injectables Vaccines
• Oral Vaccines

Global Cholera Vaccines Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Cholera Vaccines Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults
• Children

Global Cholera Vaccines Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cholera Vaccines Market Size & CAGR (2025-2032)

• North America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Valneva SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuBiologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shantha Biotechnics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hilleman Laboratories (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incepta Vaccine (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vabiotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panum Institute (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walter Reed Army Institute of Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• National Institutes of Health (NIH) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Health Organization (WHO) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centers for Disease Control and Prevention (CDC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medecins Sans Frontieres (MSF) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PATH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations